Citadel Advisors’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-25,255
| Closed | -$1.82M | – | 14107 |
|
|
2020
Q4 | $1.82M | Buy |
25,255
+10,707
| +74% | +$560K | ﹤0.01% | 5528 |
|
|
2020
Q3 | $664K | Sell |
14,548
-6,295
| -30% | -$263K | ﹤0.01% | 6790 |
|
|
2020
Q2 | $942K | Sell |
20,843
-48,554
| -70% | -$2.18M | ﹤0.01% | 5941 |
|
|
2020
Q1 | $2.67M | Buy |
69,397
+56,611
| +443% | +$2.61M | ﹤0.01% | 3658 |
|
|
2019
Q4 | $592K | Sell |
12,786
-80,361
| -86% | -$3.48M | ﹤0.01% | 6549 |
|
|
2019
Q3 | $3.79M | Sell |
93,147
-32,980
| -26% | -$1.42M | ﹤0.01% | 3500 |
|
|
2019
Q2 | $6.07M | Buy |
126,127
+104,086
| +472% | +$5.47M | ﹤0.01% | 2815 |
|
|
2019
Q1 | $1.38M | Sell |
22,041
-73,909
| -77% | -$5.08M | ﹤0.01% | 5042 |
|
|
2018
Q4 | $5.73M | Buy |
95,950
+59,694
| +165% | +$3.58M | ﹤0.01% | 2595 |
|
|
2018
Q3 | $2.34M | Buy |
36,256
+31,308
| +633% | +$1.75M | ﹤0.01% | 4146 |
|
|
2018
Q2 | $223K | Sell |
4,948
-10,062
| -67% | -$401K | ﹤0.01% | 7708 |
|
|
2018
Q1 | $466K | Buy |
+15,010
| New | +$494K | ﹤0.01% | 5996 |
|
|
2017
Q4 | – | Sell |
-61,343
| Closed | -$1.78M | – | 8840 |
|
|
2017
Q3 | $2.02M | Buy |
+61,343
| New | +$2.12M | ﹤0.01% | 3395 |
|
|
2017
Q2 | – | Sell |
-55,647
| Closed | -$1.66M | – | 8595 |
|
|
2017
Q1 | $1.61M | Buy |
55,647
+44,895
| +418% | +$1.11M | ﹤0.01% | 3335 |
|
|
2016
Q4 | $240K | Sell |
10,752
-59,463
| -85% | -$1.16M | ﹤0.01% | 6021 |
|
|
2016
Q3 | $1.3M | Buy |
70,215
+18,677
| +36% | +$352K | ﹤0.01% | 3499 |
|
|
2016
Q2 | $840K | Buy |
51,538
+21,020
| +69% | +$309K | ﹤0.01% | 3783 |
|
|
2016
Q1 | $356K | Sell |
30,518
-105,164
| -78% | -$1.18M | ﹤0.01% | 4874 |
|
|
2015
Q4 | $1.58M | Sell |
135,682
-10,451
| -7% | -$132K | ﹤0.01% | 3008 |
|
|
2015
Q3 | $1.79M | Buy |
146,133
+27,043
| +23% | +$345K | ﹤0.01% | 3092 |
|
|
2015
Q2 | $1.12M | Sell |
119,090
-7,119
| -6% | -$65.9K | ﹤0.01% | 3806 |
|
|
2015
Q1 | $1.12M | Buy |
126,209
+16,726
| +15% | +$169K | ﹤0.01% | 3777 |
|
|
2014
Q4 | $1.1M | Buy |
109,483
+15,184
| +16% | +$130K | ﹤0.01% | 3657 |
|
|
2014
Q3 | $633K | Buy |
94,299
+57,955
| +159% | +$406K | ﹤0.01% | 4319 |
|
|
2014
Q2 | $260K | Sell |
36,344
-43,672
| -55% | -$348K | ﹤0.01% | 5246 |
|
|
2014
Q1 | $807K | Buy |
80,016
+38,902
| +95% | +$358K | ﹤0.01% | 3702 |
|
|
2013
Q4 | $326K | Buy |
41,114
+27,113
| +194% | +$253K | ﹤0.01% | 4517 |
|
|
2013
Q3 | $139K | Buy |
14,001
+3,547
| +34% | +$27.9K | ﹤0.01% | 5087 |
|
|
2013
Q2 | $62K | Buy |
+10,454
| New | +$35.2K | ﹤0.01% | 5554 |
|
Other funds holding BEAT
Citadel Advisors's BEAT Position: Q1 2021 in Review
Citadel Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 25,255 shares — an estimated $1.82M sold.
Citadel Advisors first reported a position in BEAT in Q2 2013 and held it in 29 quarters. The position peaked at $6.07M in Q2 2019. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Citadel Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Citadel Advisors sold 25,255 BioTelemetry, Inc. shares in Q1 2021, an estimated $1.82M.
- Citadel Advisors first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 29 quarters.
- Citadel Advisors's BioTelemetry, Inc. position peaked at $6.07M in Q2 2019.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Citadel Advisors's 13F filing for Q1 2021, filed 17 May 2021.